April 8, 2026 BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
April 8, 2026 Rawcology Ignites Next Phase of Growth with Strategic Joint Venture, Unlocking National Scale and Global Expansion
